CLDI.WS
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
CLDI.WS
Delisted
CLDI.WS was delisted on the 17th of October, 2024.
24 hedge funds and large institutions have $3.48M invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
5
Closed
2
Calls
$4.99M
Puts
–
Net Calls
+$4.99M
Net Calls Change
+$155K
Top Buyers
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
$18.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$150 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BFM
26
Boothbay Fund Management
New York
| – | -$223K | -22,626 | Closed |
|
27
JPMorgan Chase & Co
New York
| – | -$8K | – | – |
|